CLINUVEL PHARMACEUTICALS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.315 EUR | -0.59% |
|
-0.75% | -6.14% |
| 06-28 | Clinuvel Pharmaceuticals Limited Announces Change of Company Secretary | CI |
| 06-24 | Clinuvel Pharmaceuticals Secures Orphan Drug Designation in Europe for Metabolic Disorder Drug | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 95.18B | ||||||
| 37.55B | ||||||
| 28.2B | ||||||
| 15.63B | ||||||
| 13.63B |
